Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease?

Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease?

Bibliographic Details
Main Authors:	Francesco Marongiu, Doris Barcellona
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2020-10-01
Series:	TH Open
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1719232

Similar Items

Fondaparinux
by: G. Airoldi, et al.
Published: (2013-05-01)

The hemostatic system. 1st Part
by: Doris Barcellona, et al.
Published: (2019-11-01)

Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study
by: Cardillo G, et al.
Published: (2021-02-01)

Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study
by: Vincenzo Russo, et al.
Published: (2020-11-01)

Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients
by: Paraskevi C. Fragkou, et al.
Published: (2022-05-01)

Management of acute coronary syndromes with fondaparinux
by: Harm Wienbergen, et al.
Published: (2007-07-01)

FONDAPARINUX IN THE TREATMENT OF ACUTE CORONARY SYNDROME
by: O. O. Shakhmatova
Published: (2017-05-01)

Living on Oral Anticoagulants: Duke Anticoagulation Satisfaction Scale Results
by: Antonella Mameli, et al.
Published: (2023-12-01)

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction
by: Alexander GG Turpie
Published: (2006-12-01)

Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis
by: Kušić Jovana, et al.
Published: (2016-01-01)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
by: Michelangelo Sartori, et al.
Published: (2020-10-01)

Fondaparinux Sodium: Recent Advances in the Management of Thrombosis
by: Rupert M. Bauersachs MD
Published: (2023-01-01)

Can this be considered a Fondaparinux-induced Thrombocytopenia?
by: Barbara Mariotti, et al.
Published: (2014-04-01)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
by: Amato B, et al.
Published: (2016-06-01)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
by: Abdel-Razeq H, et al.
Published: (2016-08-01)

Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra)
by: Hend H Metwali, et al.
Published: (2016-01-01)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
by: Shimizu K, et al.
Published: (2018-02-01)

Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study
by: Ramadan A, et al.
Published: (2011-11-01)

Clinical experience with fondaparinux in antiaggregate patients undergoing total hip and knee arthroplasty
by: Guido Grappiolo, et al.
Published: (2013-09-01)

Recurrent thrombosis rescued by fondaparinux in high‐risk patients: A case series
by: Mégane Tanguay, et al.
Published: (2022-07-01)

Risk factors for bleeding in patients receiving fondaparinux after colorectal cancer surgery
by: Jongsung Pak, et al.
Published: (2017-10-01)

Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery
by: David Bergqvist
Published: (2006-12-01)

Fondaparinux versus enoxaparin in the management of acute coronary syndromes in Switzerland
by: Michel Pierre Kossovsky, et al.
Published: (2012-03-01)

Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01)

FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
by: G. V. Mardaryan, et al.
Published: (2015-09-01)

Comparative Evaluation of Efficacy, Safety and Haemostatic Parameters of Enoxaparin and Fondaparinux in Unstable Coronary Artery Disease
by: Sanjay Shah, et al.
Published: (2014-01-01)

Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
by: Barcellona D, et al.
Published: (2018-08-01)

Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023)
by: Qinan Yin, et al.
Published: (2024-03-01)

Effect of fondaparinux on viability and ischemia reperfusion injury in the abdominal perforator flap
by: Guler Gamze Eren Ozcan, et al.
Published: (2020-01-01)

Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide
by: Gulab Walke, et al.
Published: (2021-02-01)

Custo-efetividade de fondaparinux em pacientes com Síndrome Coronariana Aguda sem supradesnivelamento do ST Cost-effectiveness of fondaparinux in patients with acute coronary syndrome without ST-segment Elevation
by: Camila Pepe, et al.
Published: (2012-07-01)

Fondaparinux and acute coronary syndromes: update on the OASIS 5&ndash;6 studies
by: Fran&ccedil;ois Schiele
Published: (2010-03-01)

Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase
by: Mohamed S. Abdel-Bakky, et al.
Published: (2023-06-01)

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP)
by: Carl-Erik Dempfle MD, et al.
Published: (2021-05-01)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review
by: Amy Christopher
Published: (2016-12-01)

Efficacy and safety of fondaparinux in preventing venous thromboembolism in Chinese cancer patients: a single-arm, multicenter, retrospective study
by: Lei Wang, et al.
Published: (2023-05-01)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-01-01)

Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2017-05-01)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
by: Alex C Spyropoulos, et al.
Published: (2008-06-01)

Successful use of fondaparinux for perioperative bridging in a patient with a mechanical heart valve and heparin-induced thrombocytopenia
by: C R Pruthvi, et al.
Published: (2019-01-01)